Common coronavirus infections cannot produce antibodies against COVID-19
Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans.
But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally...
Why diabetes is a big risk factor for severe COVID-19
More than 40% of hospitalized individuals with COVID-19 have diabetes. But why is having diabetes a major risk factor for a more serious COVID-19...
This antiviral drug could eliminate COVID-19 by day 3 of treatment
Scientists found that people taking the new anti-COVID drug molnupiravir eliminate SARS-CoV-2 virus by day three of starting therapy, while many participants who received...
People with ‘hybrid immunity’ have best COVID-19 protection
Scientists found that people with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against...
Some people with asthma may have greater COVID-19 risk
Scientists from Imperial College London and elsewhere found that children and adults with asthma that is severe or poorly controlled are at greater risk...
After COVID-19, watch for these potential heart and brain problems
COVID-19 was full of surprises early on, causing mild problems in the short term for some people and serious complications for others.
Long term, it...
Second booster approved as option for additional protection against COVID-19
On March 29 the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a...
Diabetes risk increases after COVID-19, study finds
Scientists from the VA Saint Louis Health Care System found the risk of diabetes is increased for people after the COVID-19 infection.
The research is...
This new sensor could revolutionize COVID-19 testing
A COVID-19 sensor developed at Johns Hopkins University could revolutionize virus testing by adding accuracy and speed to a process that frustrated many during...
Second COVID-19 booster: who can get one, and when?
Following much debate among public health experts about the benefits of another COVID-19 booster, the U.S. Food and Drug Administration could approve second boosters...